APAC Life Sciences and Health Care Webinar Series - Spotlight on Greater China - Session 5

Webinar No. 5: How to navigate antitrust and regulatory risks in life sciences distribution channels in Greater China

We are delighted to invite you to the fifth session of our APAC Life Sciences and Health Care webinar series on Tuesday, 4 April 2023.

Join us for an informative panel discussion on the latest antitrust and regulatory developments in the life sciences sector in Greater China. Amongst other things, we will explore:

  • The multiple recent antitrust developments affecting the life sciences sector in Mainland China, including the amendment of the Anti-Monopoly Law – with a possible ‘safe harbour’ for determining distributors’ resale prices – and a series of new enforcement cases against distributor resale price obligations imposed by life sciences companies
  • The first enforcement cases in Hong Kong against restrictions on distributor resale pricing and against a life sciences company
  • The first pharmacovigilance rules in Mainland China, discussing the increasing significance of pharmacovigilance and providing practical checkpoints for drug marketing authorization holders
  • An update on regulatory requirements for launching a new pharmaceutical product in Hong Kong

If you have any questions, please submit them in advance and our speakers will seek to address them during the webinar.

We hope you can join us.

Register here

Back To Listing